Literature DB >> 11162514

Molecular characterization of the genomic breakpoint junction in the t(11;18) (q21;q21) translocation of a gastric MALT lymphoma.

Y Sato1, Y Akiyama, T Tanizawa, T Shibata, K Saito, S Mori, R Kamiyama, Y Yuasa.   

Abstract

The t(11;18) translocation, fusing the API2 and MALT1 genes, is one of the most frequent chromosomal translocations associated with mucosa-associated lymphoid tissue (MALT) lymphomas. The translocation breakpoints have been cloned and characterized at the mRNA sequence level. Although the genomic organization of the API2 gene has been described, hitherto the genomic sequence of MALT1 remains unknown. To gain some insight into the mechanism that generates this translocation, we cloned and sequenced an API2-MALT1 fused transcript as well as genomic DNA of the t(11;18) translocation from a MALT lymphoma. We localized the API2 breakpoint within intron 7. Nucleotide sequence analysis revealed that the genomic breakpoint junction possesses the consensus heptamers of immunoglobulin V(D)J recombination signal sequences, all the matches being completely present on the API2 allele and five of seven matches on the MALT1 allele. These data suggest that the translocation in the MALT lymphoma might have been mediated in part by an aberrant V(D)J recombination event. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11162514     DOI: 10.1006/bbrc.2000.4124

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  The t(14;18)(q32;q21)/IGH-MALT1 translocation in MALT lymphomas is a CpG-type translocation, but the t(11;18)(q21;q21)/API2-MALT1 translocation in MALT lymphomas is not.

Authors:  Albert G Tsai; Zhengfei Lu; Michael R Lieber
Journal:  Blood       Date:  2010-04-29       Impact factor: 22.113

2.  Agmatine (decarboxylated arginine), a modulator of liver cell homeostasis and proliferation.

Authors:  Bettina Kribben; Jörg Heller; Jonel Trebicka; Tilman Sauerbruch; Michael Brüss; Manfred Göthert; Gerhard J Molderings
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-01-15       Impact factor: 3.000

3.  EGFR Intron Recombination in Human Gliomas: Inappropriate Diversion of V(D)J Recombination?

Authors:  Robert A Fenstermaker; Michael J Ciesielski
Journal:  Curr Genomics       Date:  2007-05       Impact factor: 2.236

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.